IBC’s 7th Annual OTC Pharma Asia is bringing key experts in OTC and VMS to address pertinent issues in Asia – the changing consumer buying behavior and consumer-centric marketing as well as product innovation strategies. The ultimate platform in Asia center staging top leaders in OTC drugs, global pharma manufacturers, retailers, FMCGs, government and regulatory bodies and pharmacies to highlight winning strategies in Asia how OTC and consumer healthcare medicines are accessible, affordable and trusted self-care solutions.
SETA is Asia’s premier sustainable energy and technology platform that brings together leaders from the public, private, civic and academic sectors to showcase and promote new technology in energy. The event is co-organised by the Ministry of Energy of Thailand and Chulalongkorn University, and endorsed by the Ministry of Science and Technology and Ministry of Transport of Thailand. SETA 2017 targets to draw in over 200 exhibitors and supporting organizations with over 10,000 participants from more than fifty countries.
Location: BITEC | Bangkok International Trade & Exhibition Centre, Bangkok, Thailand
This 2017, the 2nd Annual Pharmaceutical Congress China, part of IBC’s PharmaCon Series will co-locate 3 events: Pharmaceutical Compliance, Patient-Centered Clinical Trials and Clinical Trials Site Selection & Quality. From addressing pharmaceutical compliance challenges and issues, driving clinical operation efficiencies and discovering new clinical design technologies, to clinical trials site selection and quality assurance, Pharmacon China 2017 promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry.
The Biopharma Development & Production (BDP) China is the leading industry platform in China for pharma, biotech, CMOs, CROs, research institutes, investors, technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia. This year, BDP China will feature 3 co-located events: 7th Annual Biosimilars Asia, 6th Annual Biomanufacturing and the 5th Annual Cell Line Development and Engineering.
IBC’s Asia Healthcare Summit is the leading gathering for Government, public and private healthcare providers, health insurance companies, medical equipment/service providers and health technology, to discuss investment in healthcare infrastructure and services to meet Asia’s ageing population, chronic disease burden and growing healthcare services demand. It is the MUST-ATTEND platform to learn, meet, network and establish business partnerships in Asia’s healthcare sector.
A member of our Client Services team will be in touch soon to arrange a convenient time for a free demonstration of the service. If your enquiry is urgent, please email our team here.
Thanks, BMI Research